↓ Skip to main content

Chinese Patent Medicines in the Treatment of Coronavirus Disease 2019 (COVID-19) in China

Overview of attention for article published in Frontiers in Pharmacology, July 2020
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (60th percentile)
  • Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

twitter
4 X users

Citations

dimensions_citation
79 Dimensions

Readers on

mendeley
137 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Chinese Patent Medicines in the Treatment of Coronavirus Disease 2019 (COVID-19) in China
Published in
Frontiers in Pharmacology, July 2020
DOI 10.3389/fphar.2020.01066
Pubmed ID
Authors

Wei Zhuang, Zheng Fan, Yanqi Chu, Haizheng Wang, Ying Yang, Li Wu, Nan Sun, Ge Sun, Yuqiao Shen, Xiaolan Lin, Guiming Guo, Shengyan Xi

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 137 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 137 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 16 12%
Student > Ph. D. Student 10 7%
Other 9 7%
Researcher 9 7%
Student > Master 9 7%
Other 27 20%
Unknown 57 42%
Readers by discipline Count As %
Medicine and Dentistry 28 20%
Nursing and Health Professions 10 7%
Pharmacology, Toxicology and Pharmaceutical Science 8 6%
Biochemistry, Genetics and Molecular Biology 4 3%
Social Sciences 4 3%
Other 16 12%
Unknown 67 49%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 May 2021.
All research outputs
#7,330,855
of 23,292,144 outputs
Outputs from Frontiers in Pharmacology
#3,131
of 16,725 outputs
Outputs of similar age
#143,291
of 366,591 outputs
Outputs of similar age from Frontiers in Pharmacology
#97
of 428 outputs
Altmetric has tracked 23,292,144 research outputs across all sources so far. This one has received more attention than most of these and is in the 68th percentile.
So far Altmetric has tracked 16,725 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.0. This one has done well, scoring higher than 80% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 366,591 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.
We're also able to compare this research output to 428 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 77% of its contemporaries.